BioSpace News Archive

Daxor Corporation, the global leader in blood volume measurement technology, announces joining the Heart Failure Society of America as a corporate member to collaborate and deepen engagement with leaders in the field of heart failure.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the European Patent Office (EPO) has provided a Notice of Allowance for a patent covering methods for the use of histidyl-tRNA synthetase (HARS) Fc fusion proteins for reducing inflammation or fibrosis in the lung.

Apexigen, Inc. (NASDAQ: APGN) a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced the presentation of new data from Phase 2 multicenter clinical trials evaluating sotigalimab (sotiga), Apexigen’s agonist antibody targeting CD40, in two poster presentations at the ASCO Gastrointestinal Cancers Symposium.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) today announced that the U.S. Food and Drug Administration (FDA) has accepted Intercept’s New Drug Application (NDA) for obeticholic acid (OCA) seeking accelerated approval for the treatment of patients with pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis (NASH).

DM Clinical Research, a national network of clinical trial sites, has opened its first research location in the Boston metropolitan area and Massachusetts.

Eurofins CellTx, an industry leader in regulated testing services for living donor eligibility testing, announced the official opening of its new laboratory in Tucson, AZ.

Halia Therapeutics today announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer.

Renibus Therapeutics today announced that an oral presentation will be delivered on the positive results of RBT-1 from a Phase 2 Study at the Society for Critical Care Medicine (SCCM) 2023 Critical Care Congress at the Moscone Center in San Francisco, CA from January 21- 24, 2023.

German medical device manufacturer PARI and smartShift, leading global provider of Intelligent Automation for SAP transformations based in Mannheim/Germany, announce their collaboration on the planned S/4HANA transformation for PARI group’s validated SAP systems.

PTC Therapeutics, Inc. announced that the National Institute for Health and Care Excellence has issued a Final Evaluation Document recommending Translarna™ for reimbursement and use across the National Health Service in England and Wales.